scispace - formally typeset
L

L. A. Dieleman

Researcher at University of North Carolina at Chapel Hill

Publications -  21
Citations -  3703

L. A. Dieleman is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Colitis & Cecum. The author has an hindex of 16, co-authored 21 publications receiving 3418 citations. Previous affiliations of L. A. Dieleman include University of Alberta.

Papers
More filters
Journal ArticleDOI

Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice.

TL;DR: Results demonstrate that L. plantarum can attenuate immune-mediated colitis and suggest a potential therapeutic role for this agent in clinical inflammatory bowel diseases.
Journal ArticleDOI

Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.

TL;DR: It is suggested that a subset of resident luminal bacteria induces colitis, but that a complex interaction of commensal aerobic and anaerobic bacteria provides the constant antigenic drive for chronic immune-mediated colonic inflammation.
Journal ArticleDOI

Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2

TL;DR: COX-1 and COX-2 share a crucial role in the defense of the intestinal mucosa (with inducible COX -2 being perhaps more active during inflammation) and that neither isoform is essential in maintaining mucosal homeostasis in the absence of injurious stimuli.
Journal ArticleDOI

Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment

TL;DR: It is suggested that antibiotics and probiotic agents provide synergistic therapeutic effects, perhaps mediated by altered immunomodulation with selective activity of different lactobacillus species in the prevention of recurrent colitis.